INTERACTION OF CAMPTOTHECIN DERIVATIVES WITH HUMAN PLASMA-PROTEINS INVITRO

被引:7
作者
KURONO, Y
MIYAJIMA, M
IKEDA, K
机构
[1] Faculty of Pharmaceutical Sciences, Nagoya City University, Mizuho-ku, Nagoya 467
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 1993年 / 113卷 / 02期
关键词
PROTEIN BINDING; HUMAN SERUM ALBUMIN; ALPHA-1-ACID GLYCOPROTEIN; CAMPTOTHECIN; CISPLATIN; COMPETITION;
D O I
10.1248/yakushi1947.113.2_167
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interactions of camptothecin (CPT) and its derivatives (CPT-11 and SN-38) with human plasma proteins (serum albumin (HSA) and alpha1-acid glycoprotein (alpha1-AGP)) were studied mainly by means of ultraviolet and fluorescence spectroscopy. The binding constants of lactone ring-opened forms (A form) of CPT and CPT-11 with HSA were larger than those of the intact lactone forms (L form). In the case of SN-38, there was no difference in the constants between A form and L form. The binding constant of CPT (A form) with HSA was larger than those of CPT-11 and SN-38. The presence of cisplatin, which is presumed to be coadministered with CPT derivatives, did not affect the interaction of CPT derivatives with HSA. Only L form of CPT-11 among the CPT derivatives examined interacted with alpha1-AGP, followed by quenching the fluorescence of alpha1-AGP.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 33 条
[1]   A SPECTROPHOTOMETRIC INVESTIGATION OF THE INTERACTION OF IODINE WITH AROMATIC HYDROCARBONS [J].
BENESI, HA ;
HILDEBRAND, JH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1949, 71 (08) :2703-2707
[2]  
Brown J. R, 1977, ALBUMIN STRUCTURE FU, P27
[3]   3-DIMENSIONAL STRUCTURE OF HUMAN-SERUM ALBUMIN [J].
CARTER, DC ;
HE, XM ;
MUNSON, SH ;
TWIGG, PD ;
GERNERT, KM ;
BROOM, MB ;
MILLER, TY .
SCIENCE, 1989, 244 (4909) :1195-1198
[4]   STRUCTURE OF HUMAN SERUM-ALBUMIN [J].
CARTER, DC ;
HE, XM .
SCIENCE, 1990, 249 (4966) :302-303
[5]  
CHEN RF, 1967, J BIOL CHEM, V242, P173
[6]  
CHIGNELL CF, 1972, METHOD PHARMACOL, V2, P33
[7]   THE LOCATION OF DRUG-BINDING SITES IN HUMAN-SERUM ALBUMIN [J].
FEHSKE, KJ ;
MULLER, WE ;
WOLLERT, U .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (07) :687-692
[8]  
FEHSKE KJ, 1982, MOL PHARMACOL, V21, P387
[9]  
GLASSON S, 1980, MOL PHARMACOL, V17, P187
[10]  
GOTTLIEB JA, 1970, CANCER CHEMOTH REP 1, V54, P461